Loading...
New

Drug Screening Laboratory Services Market by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027

A06642
Pages: 220
Jul 2020 | 628 Views
 
Author(s) : Kavita Joshi, Ravi Telugunta , Onkar Sumant
Tables: 104
Charts: 35
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Drug Screening Laboratory Services Market

Request Now !

Drug Screening Laboratory Services Market Overview:

The global drug screening laboratory services market size was valued at $6,720 million in 2019, and is projected to reach $7,050 million by 2027, registering a CAGR of 9.4% from 2020 to 2027. 

Drug screening tests examine biological samples such as blood, hair, & urine to detect substance addiction or its metabolites in the body of a patient. Drug screening tests are used to evaluate if a person is or was under the influence of a drug or drugs at a certain point of time. It is a quick and painless technical analysis. Drug screening devices have improved, leading to implementation of emerging technologies that offer reliable and accurate results for consumers. Employers implement drug screening tests to maintain a safe, clean, and healthy workforce, which helps to increase high productivity and a suitable work environment. 

Drug Screening Laboratory Services Market

Get more information on this report : Request Sample Pages

 

Growth of the global drug screening laboratory services market is majorly driven by surge in awareness against drug abuse and stringent government regulations regarding drug abuse. In addition, rise in in funding for drug screening is anticipated to drive growth of drug screening products in the future. However, consideration of drug screening as a violation of rights and impact of COVID-19 pandemic on the drug screening services restricts the market growth On the contrary, development of novel drug screening tests and tapping emerging markets are expected to provide significant profitable opportunities for manufacturers in the drug screening laboratory services industry.

COVID-19 pandemic, which started from Wuhan city of China, has widespread across the globe. The pandemic has negatively affected the drug screening laboratory market, owing to adoption of lockdown across the globe. The pandemic has led to a number of workplace shut-downs and quarantines. Moreover, all sectors including transport, retail, and oil & gas are experiencing a slowdown in business, owing to the pandemic, which, in turn, has affected the drug screening laboratory services market. In addition, not much new jobs are generating in the pandemic and pre-employment drug testing services are majorly hampered. Drug screening service providers are also experiencing lesser demand for screening services from employers during this pandemic, which, in turn, restricts the drug screening laboratory services market growth.

The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service type, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Service Type segment review

By service type, the workplace segment dominated the global drug screening laboratory services market in 2019, and is anticipated to continue this trend during the forecast period. The key factors that drive the market growth include increase in use of drugs and alcohol consumption by employees, which compels organizations to carry out regular drug tests.

Drug Screening Laboratory Services Market
By Type

Your browser does not support the canvas element.

Workplace segment held the dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Sample type segment review

By sample, the urine sample segment accounted for majority of the drug screening laboratory services market share in 2019, owing to rise in adoption of point of care drug screening, rapid & easy drug screening, and detection multiple drug abuses in one test. The hair sample segment is expected to be the fastest growing segment from 2020 to 2027, owing to benefits such as non-invasive nature, low risk of sample tampering, and shorter detection window.

North America accounted for majority of the market share of the global drug screening laboratory services market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to rise in use of alcohol and illicit drugs at workplaces, higher adoption of drug screening products, rise in government funding for drug testing, and increase in demand for new drug testing technologies such as fuel cell breath analyzers. On the other side, Europe is expected to experience highest growth rate during the forecast period, majorly owing to increase in prevalent incidences of drug abuse & drug addiction, rise in healthcare reforms, and technological advancements in the field of healthcare.

Drug Screening Laboratory Services Market
By Sample

Your browser does not support the canvas element.

Hair segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Some of the key players operating in the drug screening laboratory services market include Abbott Laboratories (Alere Inc.), Quest Diagnostics Incorporated., Clinical Reference Laboratory, Inc, Laboratory Corporation of America Holdings, Sterling Healthcare Opco, Llc/Cordant Health Solutions, Acm Global Laboratories, Inc, Omega Laboratories, Psychemedics, Millennium Health, Mayo Foundation For Medical Education and Research, and Precision Diagnostics.

Drug Screening Laboratory Services Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

North America region would exhibit the highest CAGR of 11.3% during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders:

  • The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the drug screening laboratory services market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing drug screening laboratory services market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.
  • Key market players and their strategies have been analysed to understand the competitive outlook of the market.

Key Market Segments:

By Service Type

  • Workplace Drug Testing
  • Clinical Toxicology 

By Sample Type

  • Urine Sample
  • Oral Fluid Sample
  • Hair Sample
  • Others

By End User

  • Retail
  • Oil and Gas
  • Transportation
  • Staffing
  • Government 
  • Other Workplaces
  • Hospital Laboratories
  • Clinical Laboratories
  • Other Laboratories

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter’s five force analysis
3.3.Key findings

3.3.1.Top Investment Pockets

3.4.Regulations
3.5.Market share analysis
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Stringent government regulations regarding drug abuse
3.6.1.2.Rise in awareness against drug abuse
3.6.1.3.Surge in funding for drug screening

3.6.2.Restraints

3.6.2.1.Consideration of drug screening as a violation of rights
3.6.2.2.Negative impact of COVID-19 pandemic on the drug screening market

3.6.3.Opportunities

3.6.3.1.Development of novel drug screening tests
3.6.3.2.Tapping emerging markets

3.7.COVID-19 impact on the market

CHAPTER 4:DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Workplace drug testing

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Clinical toxicology testing

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Urine

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Oral fluid

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Hair

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Oil & gas

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Transportation

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Staffing

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

6.6.Government

6.6.1.Market size and forecast
6.6.2.Market analysis, by country

6.7.Other workplaces

6.7.1.Market size and forecast
6.7.2.Market analysis, by country

6.8.Hospital laboratories

6.8.1.Market size and forecast
6.8.2.Market analysis, by country

6.9.Clinical laboratories

6.9.1.Market size and forecast
6.9.2.Market analysis, by country

6.10.Other laboratories

6.10.1.Market size and forecast
6.10.2.Market analysis, by country

CHAPTER 7:DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. drug screening laboratory services market, by services
7.2.2.1.2.U.S. drug screening laboratory services market, by sample type
7.2.2.1.3.U.S. drug screening laboratory services market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada drug screening laboratory services market, by services
7.2.2.2.2.Canada drug screening laboratory services market, by sample type
7.2.2.2.3.Canada drug screening laboratory services market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico drug screening laboratory services market, by services
7.2.2.3.2.Mexico drug screening laboratory services market, by sample type
7.2.2.3.3.Mexico drug screening laboratory services market, by end user

7.2.3.North America market size and forecast, by services
7.2.4.North America market size and forecast, by sample type
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany drug screening laboratory services market, by services
7.3.2.1.2.Germany drug screening laboratory services market, by sample type
7.3.2.1.3.Germany drug screening laboratory services market, by end user

7.3.2.2.France

7.3.2.2.1.France drug screening laboratory services market, by services
7.3.2.2.2.France drug screening laboratory services market, by sample type
7.3.2.2.3.France drug screening laboratory services market, by end user

7.3.2.3.UK

7.3.2.3.1.UK drug screening laboratory services market, by services
7.3.2.3.2.UK drug screening laboratory services market, by sample type
7.3.2.3.3.UK drug screening laboratory services market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy drug screening laboratory services market, by services
7.3.2.4.2.Italy drug screening laboratory services market, by sample type
7.3.2.4.3.Italy drug screening laboratory services market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain drug screening laboratory services market, by services
7.3.2.5.2.Spain drug screening laboratory services market, by sample type
7.3.2.5.3.Spain drug screening laboratory services market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe drug screening laboratory services market, by services
7.3.2.6.2.Rest of Europe drug screening laboratory services market, by sample type
7.3.2.6.3.Rest of Europe drug screening laboratory services market, by end user

7.3.3.Europe market size and forecast, by services
7.3.4.Europe market size and forecast, by sample type
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan drug screening laboratory services market, BY SERVICES
7.4.2.1.2.Japan drug screening laboratory services market, by sample type
7.4.2.1.3.Japan drug screening laboratory services market, by end user

7.4.2.2.China

7.4.2.2.1.China drug screening laboratory services market, by services
7.4.2.2.2.China drug screening laboratory services market, by sample type
7.4.2.2.3.China drug screening laboratory services market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia drug screening laboratory services market, by services
7.4.2.3.2.Australia drug screening laboratory services market, by sample type
7.4.2.3.3.Australia drug screening laboratory services market, by end user

7.4.2.4.India

7.4.2.4.1.India drug screening laboratory services market, by services
7.4.2.4.2.India drug screening laboratory services market, by sample type
7.4.2.4.3.India drug screening laboratory services market, by end user

7.4.2.5.Rest of Asia-Pacific

7.4.2.5.1.Rest of Asia-Pacific drug screening laboratory services market, by services
7.4.2.5.2.Rest of Asia-Pacific drug screening laboratory services market, by sample type
7.4.2.5.3.Rest of Asia-Pacific drug screening laboratory services market, by end user

7.4.3.Asia-Pacific market size and forecast, by services
7.4.4.Asia-Pacific market size and forecast, by sample type
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil drug screening laboratory services market, by services
7.5.2.1.2.Brazil drug screening laboratory services market, by sample type
7.5.2.1.3.Brazil drug screening laboratory services market, by end user

7.5.2.2.South Africa

7.5.2.2.1.South Africa drug screening laboratory services market, by services
7.5.2.2.2.South Africa drug screening laboratory services market, by sample type
7.5.2.2.3.South Africa drug screening laboratory services market, by end user

7.5.2.3.Saudi Arabia

7.5.2.3.1.Saudi Arabia drug screening laboratory services market, by services
7.5.2.3.2.Saudi Arabia drug screening laboratory services market, by sample type
7.5.2.3.3.Saudi Arabia drug screening laboratory services market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA drug screening laboratory services market, by services
7.5.2.4.2.Rest of LAMEA drug screening laboratory services market, by sample type
7.5.2.4.3.Rest of LAMEA drug screening laboratory services market, by end user

7.5.3.LAMEA market size and forecast, by services
7.5.4.LAMEA market size and forecast, by sample type
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES (ALERE)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Business performance

8.2.QUEST DIAGNOSTICS INCORPORATED

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance

8.3.CLINICAL REFERENCE LABORATORY, INC

8.3.1.Company overview
8.3.2.Company snapshot

8.4.LABORATORY CORPORATION OF AMERICA HOLDINGS

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments

8.4.4.Business performance

8.5.STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS

8.5.1.Company overview
8.5.2.Company snapshot

8.6.ACM GLOBAL LABORATORIES, INC

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Key strategic moves and developments

8.7.OMEGA LABORATORIES LIMITED

8.7.1.Company overview
8.7.2.Company snapshot

8.8.PSYCHEMEDICS CORPORATION

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Business performance
8.8.5.Key strategic moves and developments

8.9.PRECISION DIAGNOSTICS

8.9.1.Company overview
8.9.2.Company snapshot

8.10.MILLENNIUM HEALTH

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Key strategic moves and developments

8.11.MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

8.11.1.Company overview
8.11.2.Company snapshot

LIST OF TABLES

TABLE 01.DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES TYPE, 2019–2027 ($MILLION)
TABLE 02.DRUG SCREENING LABORATORY SERVICES MARKET FOR WORKPLACE DRUG TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 03.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL TOXICOLOGY TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 04.DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027 ($MILLION)
TABLE 05.URINE DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.ORAL FLUID DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.HAIR DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 08.OTHERS DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 10.DRUG SCREENING LABORATORY SERVICES MARKET FOR RETAIL, BY REGION, 2019–2027 ($MILLION)
TABLE 11.DRUG SCREENING LABORATORY SERVICES MARKET FOR OIL & GAS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.DRUG SCREENING LABORATORY SERVICES MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 13.DRUG SCREENING LABORATORY SERVICES MARKET FOR STAFFING, BY REGION, 2019–2027 ($MILLION)
TABLE 14.DRUG SCREENING LABORATORY SERVICES MARKET FOR GOVERNMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 15.DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER WORKPLACES, BY REGION, 2019–2027 ($MILLION)
TABLE 16.DRUG SCREENING LABORATORY SERVICES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 17.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 18.DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 19.DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 22.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 23.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 24.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 25.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 26.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 27.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 28.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 29.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 30.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 31.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 32.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 33.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 34.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 35.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 36.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 37.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 38.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 39.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 40.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 41.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 42.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 43.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 44.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 45.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 46.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 47.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 48.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 49.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 50.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 51.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 52.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 53.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 54.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 55.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 56.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 57.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 58.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 59.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 60.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 61.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 62.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 63.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 64.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 65.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 66.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 67.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 68.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 69.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 70.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 71.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 72.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 73.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 74.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 75.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 76.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 77.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 78.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 79.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 80.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 81.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 82.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 83.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 84.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 85.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 86.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 87.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019–2027
TABLE 88.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019–2027
TABLE 89.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019–2027
TABLE 90.ABBOTT: COMPANY SNAPSHOT
TABLE 91.ABBOTT: OERATING SEGMENT
TABLE 92.QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 93.QUEST DIAGNOSTICS: OPERATING BUSINESS SEGMENTS
TABLE 94.CLINICAL REFERENCE LABORATORY: COMPANY SNAPSHOT
TABLE 95.LABCORP: COMPANY SNAPSHOT
TABLE 96.LABCORP: OPERATING SEGMENTS
TABLE 97.CORDANT: COMPANY SNAPSHOT
TABLE 98.ACM GLOBAL LABORATORIES: COMPANY SNAPSHOT
TABLE 99.OMEGA LABORATORIES: COMPANY SNAPSHOT
TABLE 100.PSYCHEMEDICS: COMPANY SNAPSHOT
TABLE 101.PSYCHEMEDICS: OPERATING SEGMENTS
TABLE 102.PRECISION DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 103.MILLENNIUM HEALTH: COMPANY SNAPSHOT
TABLE 104.MAYO CLINIC LABORATORIES: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01.GLOBAL DRUG SCREENING MARKET SEGMENTATION
FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW THREAT OF SUBSTITUTES
FIGURE 05.MODEARTE THREAT OF NEW ENTRANTS
FIGURE 06.HIGH INTENSITY OF RIVALRY
FIGURE 07.TOP INVESTMENT POCKETS
FIGURE 08.MARKET SHARE ANALYSIS, 2019
FIGURE 09.DRIVER, RESTRAINSTS AND OPPORTUNITIES
FIGURE 10.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR WORKPLACE DRUG TESTING, BY COUNTRY, 2019 & 2027(%)
FIGURE 11.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL TOXICOLOGY TESTING, BY COUNTRY, 2019 &2027 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF URINE DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS ORAL FLUID DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF HAIR DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF OTHERS DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET RETAIL, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OIL & GAS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR TRANSPORTATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR STAFFING, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR GOVERNMENT, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER WORKPLACES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 27.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 28.QUEST DIAGNOSTICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.QUEST DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 30.LABCORP: REVENUE, 2017–2019 ($MILLION)
FIGURE 31.LABCORP: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 32.LABCORP: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 33.PSYCHEMEDICS: REVENUE, 2017–2019 ($MILLION)
FIGURE 34.PSYCHEMEDICS: NET SALE BY SEGMENT 2019 (%)
FIGURE 35.PSYCHEMEDICS: NET SALE BY REVENUE 2019 (%)

 
 

Drug screening test uses biological samples such as urine, blood, saliva, and hair to detect the presence of drugs and drug metabolites in a person. In addition, drug screening laboratory services are increasingly being adopted by employers, and several other end users.

Moreover, increase in consumption of alcohol & illicit drugs across the globe is one of the major drivers for the drug screening market. In addition, technological advancements toward development of accurate drug screening tests, enforcement of stringent laws mandating drug & alcohol testing, rise in product launches & services, increase in awareness on drug screening policy, and rise in government funding & initiatives for drug testing fuel growth of the global drug screening market.

Furthermore, North America is expected to remain dominant during the forecast period, owing to rise in cases of drug consumption, increase in adoption of drug screening services by employers, and presence of various key providers of drug screening services. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, owing to rise in incidences of drug abuse & drug addiction, and rise in government funding for drug testing.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total value of Global Drug Screening Laboratory Services market was $6,720 million in 2019.

A. The forecast period in the report is from 2020-2027.

A. The market value of Global Drug Screening Laboratory Services market in 2020 was $3,762 million.

A. The base year calculated is 2019 in the report.

A. As per the key industry leaders, rise in drug of abuse incidences across the globe boons the market growth of global Drug Screening Laboratory Services market.

A. Surge in technological advancements in the products used for screening drugs of abuse.

A. The growth % of the emerging economies such as India, China, Australia is 11.4%, 9.5%, 10.8% respectively.

A. Workplace segment holds the maximum market share.

A. No, the report provide the value chain analysis.

A. North America market holds the maximum market share of the global market.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Drug Screening Laboratory Services Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts